Hengkang Medical Group Co., Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 1,509.16 million compared to CNY 1,472.11 million a year ago. Revenue was CNY 1,521.47 million compared to CNY 1,480 million a year ago.

Net income was CNY 50.38 million compared to net loss of CNY 49.11 million a year ago. Basic earnings per share from continuing operations was CNY 0.0154 compared to basic loss per share from continuing operations of CNY 0.0263 a year ago. Diluted earnings per share from continuing operations was CNY 0.0154 compared to diluted loss per share from continuing operations of CNY 0.0263 a year ago.